PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of taosLink to Publisher's site
 
Trans Am Ophthalmol Soc. 2001; 99: 111–132.
PMCID: PMC1359003

Curvularia keratitis.

Abstract

PURPOSE: To determine the risk factors and clinical signs of Curvularia keratitis and to evaluate the management and outcome of this corneal phaeohyphomycosis. METHODS: We reviewed clinical and laboratory records from 1970 to 1999 to identify patients treated at our institution for culture-proven Curvularia keratitis. Descriptive statistics and regression models were used to identify variables associated with the length of antifungal therapy and with visual outcome. In vitro susceptibilities were compared to the clinical results obtained with topical natamycin. RESULTS: During the 30-year period, our laboratory isolated and identified Curvularia from 43 patients with keratitis, of whom 32 individuals were treated and followed up at our institute and whose data were analyzed. Trauma, usually with plants or dirt, was the risk factor in one half; and 69% occurred during the hot, humid summer months along the US Gulf Coast. Presenting signs varied from superficial, feathery infiltrates of the central cornea to suppurative ulceration of the peripheral cornea. A hypopyon was unusual, occurring in only 4 (12%) of the eyes but indicated a significantly (P = .01) increased risk of subsequent complications. The sensitivity of stained smears of corneal scrapings was 78%. Curvularia could be detected by a panfungal polymerase chain reaction. Fungi were detected on blood or chocolate agar at or before the time that growth occurred on Sabouraud agar or in brain-heart infusion in 83% of cases, although colonies appeared only on the fungal media from the remaining 4 sets of specimens. Curvularia was the third most prevalent filamentous fungus among our corneal isolates and the most common dematiaceous mold. Corneal isolates included C senegalensis, C lunata, C pallescens, and C prasadii. All tested isolates were inhibited by 4 micrograms/mL or less of natamycin. Topical natamycin was used for a median duration of 1 month, but a delay in diagnosis beyond 1 week doubled the average length of topical antifungal treatment (P = .005). Visual acuity improved to 20/40 or better in 25 (78%) of the eyes. CONCLUSIONS: Curvularia keratitis typically presented as superficial feathery infiltration, rarely with visible pigmentation, that gradually became focally suppurative. Smears of corneal scrapings often disclosed hyphae, and culture media showed dematiaceous fungal growth within 1 week. Natamycin had excellent in vitro activity and led to clinical resolution with good vision in most patients with corneal curvulariosis. Complications requiring surgery were not common but included exophytic inflammatory fungal sequestration, treated by superficial lamellar keratectomy, and corneal perforation, managed by penetrating keratoplasty.

Full Text

The Full Text of this article is available as a PDF (987K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Jones BR, Richards AB, Morgan G. Direct fungal infection of the eye in Britain. Trans Ophthalmol Soc U K. 1970;89:727–741. [PubMed]
  • Forster RK, Rebell G, Wilson LA. Dematiaceous fungal keratitis. Clinical isolates and management. Br J Ophthalmol. 1975 Jul;59(7):372–376. [PMC free article] [PubMed]
  • Pappagianis D, Ajello L. Dematiaceous--a mycologic misnomer? J Med Vet Mycol. 1994;32(4):319–321. [PubMed]
  • Yau YC, de Nanassy J, Summerbell RC, Matlow AG, Richardson SE. Fungal sternal wound infection due to Curvularia lunata in a neonate with congenital heart disease: case report and review. Clin Infect Dis. 1994 Oct;19(4):735–740. [PubMed]
  • Fernandez M, Noyola DE, Rossmann SN, Edwards MS. Cutaneous phaeohyphomycosis caused by Curvularia lunata and a review of Curvularia infections in pediatrics. Pediatr Infect Dis J. 1999 Aug;18(8):727–731. [PubMed]
  • Rinaldi MG, Phillips P, Schwartz JG, Winn RE, Holt GR, Shagets FW, Elrod J, Nishioka G, Aufdemorte TB. Human Curvularia infections. Report of five cases and review of the literature. Diagn Microbiol Infect Dis. 1987 Jan;6(1):27–39. [PubMed]
  • ANDERSON B, ROBERTS SS, Jr, GONZALEZ C, CHICK EW. Mycotic ulcerative keratitis. AMA Arch Ophthalmol. 1959 Aug;62(2):169–197. [PubMed]
  • Brook I, Frazier EH. Aerobic and anaerobic microbiology of dacryocystitis. Am J Ophthalmol. 1998 Apr;125(4):552–554. [PubMed]
  • Sodhi Punita Kumari, Kaur Ravinder. Curvularia dacryocystitis: report of two cases. Orbit. 2000 Mar;19(1):45–50. [PubMed]
  • Heier JS, Gardner TA, Hawes MJ, McGuire KA, Walton WT, Stock J. Proptosis as the initial presentation of fungal sinusitis in immunocompetent patients. Ophthalmology. 1995 May;102(5):713–717. [PubMed]
  • Kaushik S, Ram J, Chakrabarty A, Dogra MR, Brar GS, Gupta A. Curvularia lunata endophthalmitis with secondary keratitis. Am J Ophthalmol. 2001 Jan;131(1):140–142. [PubMed]
  • Agrawal PK, Lal B, Shukla PK, Khan ZA, Srivastava OP. Clinical and experimental keratitis due to Curvularia lunata (Wakker) Boedijn var. aeria (Batista, Lima and Vasconcelos) Ellis. Sabouraudia. 1982 Sep;20(3):225–232. [PubMed]
  • Shukla PK, Khan ZA, Lal B, Agrawal PK, Srivastava OP. A study on the association of fungi in human corneal ulcers and their therapy. Mykosen. 1984 Aug;27(8):385–390. [PubMed]
  • ANDERSON B, Jr, CHICK EW. Mycokeratitis: treatment of fungal corneal ulcers with amphotericin B and mechanical debridement. South Med J. 1963 Mar;56:270–274. [PubMed]
  • Arora R, Venkateswarlu K, Mahajan VM. Keratomycosis--a retrospective histopathologic and microbiologic analysis. Ann Ophthalmol. 1988 Aug;20(8):306–315. [PubMed]
  • Berger ST, Katsev DA, Mondino BJ, Pettit TH. Macroscopic pigmentation in a dematiaceous fungal keratitis. Cornea. 1991 May;10(3):272–276. [PubMed]
  • Carmichael TR, Wolpert M, Koornhof HJ. Corneal ulceration at an urban African hospital. Br J Ophthalmol. 1985 Dec;69(12):920–926. [PMC free article] [PubMed]
  • Chander J, Sharma A. Prevalence of fungal corneal ulcers in northern India. Infection. 1994 May-Jun;22(3):207–209. [PubMed]
  • Chung MS, Goldstein MH, Driebe WT, Jr, Schwartz B. Fungal keratitis after laser in situ keratomileusis: a case report. Cornea. 2000 Mar;19(2):236–237. [PubMed]
  • Clinch TE, Robinson MJ, Barron BA, Insler MS, Liang K, Kaufman HE. Fungal keratitis from nylon line lawn trimmers. Am J Ophthalmol. 1992 Oct 15;114(4):437–440. [PubMed]
  • Clinch TE, Palmon FE, Robinson MJ, Cohen EJ, Barron BA, Laibson PR. Microbial keratitis in children. Am J Ophthalmol. 1994 Jan 15;117(1):65–71. [PubMed]
  • Dasgupta LR, Gupta AK, Ray BG, Sundararay T, Ramanurthy S, Lamba PA. Mycological studies in keratitis. Indian J Med Res. 1973 Feb;61(2):165–168. [PubMed]
  • Dorey SE, Ayliffe WH, Edrich C, Barrie D, Fison P. Fungal keratitis caused by Curvularia lunata, with successful medical treatment. Eye (Lond) 1997;11(Pt 5):754–755. [PubMed]
  • Dunlop AA, Wright ED, Howlader SA, Nazrul I, Husain R, McClellan K, Billson FA. Suppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol. 1994 May;22(2):105–110. [PubMed]
  • Fitzsimons R, Peters AL. Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. Am J Ophthalmol. 1986 May 15;101(5):605–608. [PubMed]
  • Garg P, Gopinathan U, Choudhary K, Rao GN. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology. 2000 Mar;107(3):574–580. [PubMed]
  • Grover S, Jagtap P, Sharma KD. Mycotic keratitis. Indian J Ophthalmol. 1975 Jul;23(2):7–10. [PubMed]
  • Guarro J, Akiti T, Horta RA, Morizot Leite-Filho LA, Gené J, Ferreira-Gomes S, Aguilar C, Ortoneda M. Mycotic keratitis due to Curvularia senegalensis and in vitro antifungal susceptibilities of Curvularia spp. J Clin Microbiol. 1999 Dec;37(12):4170–4173. [PMC free article] [PubMed]
  • Hagan M, Wright E, Newman M, Dolin P, Johnson G. Causes of suppurative keratitis in Ghana. Br J Ophthalmol. 1995 Nov;79(11):1024–1028. [PMC free article] [PubMed]
  • Imwidthaya P. Mycotic keratitis in Thailand. J Med Vet Mycol. 1995 Jan-Feb;33(1):81–82. [PubMed]
  • Forster RK, Rebell G. Therapeutic surgery in failures of medical treatment for fungal keratitis. Br J Ophthalmol. 1975 Jul;59(7):366–371. [PMC free article] [PubMed]
  • Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980 Jul;90(1):38–47. [PubMed]
  • Venugopal PL, Venugopal TL, Gomathi A, Ramakrishna ES, Ilavarasi S. Mycotic keratitis in Madras. Indian J Pathol Microbiol. 1989 Jul;32(3):190–197. [PubMed]
  • Luque AG, Nanni R, de Bracalenti BJ. Mycotic keratitis caused by Curvularia lunata var. aeria. Mycopathologia. 1986 Jan;93(1):9–12. [PubMed]
  • Marcus L, Vismer HF, van der Hoven HJ, Gove E, Meewes P. Mycotic keratitis caused by Curvularia brachyspora (Boedjin). A report of the first case. Mycopathologia. 1992 Jul;119(1):29–33. [PubMed]
  • Miño de Kaspar H, Zoulek G, Paredes ME, Alborno R, Medina D, Centurion de Morinigo M, Ortiz de Fresco M, Aguero F. Mycotic keratitis in Paraguay. Mycoses. 1991 May-Jun;34(5-6):251–254. [PubMed]
  • NITYANANDA K, SIVASUBRAMANIAM P, AJELLO L. A CASE OF MYCOTIC KERATITIS CAUSED BY CURVULARIA GENICULATA. Arch Ophthalmol. 1964 Apr;71:456–458. [PubMed]
  • Panda A, Sharma N, Das G, Kumar N, Satpathy G. Mycotic keratitis in children: epidemiologic and microbiologic evaluation. Cornea. 1997 May;16(3):295–299. [PubMed]
  • Poria VC, Bharad VR, Dongre DS, Kulkarni MV. Study of mycotic keratitis. Indian J Ophthalmol. 1985 Jul-Aug;33(4):229–231. [PubMed]
  • Prasad S, Nema HV. Mycotic infections of cornea. (Drug sensitivity study). Indian J Ophthalmol. 1982 Mar;30(2):81–85. [PubMed]
  • Rahman MR, Minassian DC, Srinivasan M, Martin MJ, Johnson GJ. Trial of chlorhexidine gluconate for fungal corneal ulcers. Ophthalmic Epidemiol. 1997 Sep;4(3):141–149. [PubMed]
  • Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Oral ketoconazole in Keratomycosis. Indian J Ophthalmol. 1987 Jul-Aug;35(4):197–203. [PubMed]
  • Rajasekaran J, Thomas PA, Kalavathy CM, Joseph PC, Abraham DJ. Itraconazole therapy for fungal keratitis. Indian J Ophthalmol. 1987;35(5-6):157–160. [PubMed]
  • Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy for mycotic keratitis. Mycoses. 1988 May;31(5):271–279. [PubMed]
  • Rosa RH, Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology. 1994 Jun;101(6):1005–1013. [PubMed]
  • Salceda SR. Keratomycosis with emphasis on the diagnostic and therapeutic value of anterior keratectomy. Trans Ophthalmol Soc N Z. 1973;25:202–212. [PubMed]
  • Sandhu DK, Randhawa IS. Studies on the air-borne fungal spores in Amritsar: their role in keratomycosis. Mycopathologia. 1979 Aug 31;68(1):47–52. [PubMed]
  • Sanitato JJ, Kelley CG, Kaufman HE. Surgical management of peripheral fungal keratitis (keratomycosis). Arch Ophthalmol. 1984 Oct;102(10):1506–1509. [PubMed]
  • Sridhar MS, Garg P, Das S, Vemuganti G, Gopinathan U, Rao GN. Infectious keratitis in climatic droplet keratopathy. Cornea. 2000 Jul;19(4):455–458. [PubMed]
  • Srinivasan R, Kanungo R, Goyal JL. Spectrum of oculomycosis in South India. Acta Ophthalmol (Copenh) 1991 Dec;69(6):744–749. [PubMed]
  • Srinivasan M, Gonzales CA, George C, Cevallos V, Mascarenhas JM, Asokan B, Wilkins J, Smolin G, Whitcher JP. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997 Nov;81(11):965–971. [PMC free article] [PubMed]
  • Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology. 1991 Jun;98(6):847–853. [PubMed]
  • Sundaram BM, Badrinath S, Subramanian S. Studies on mycotic keratitis. Mycoses. 1989 Nov;32(11):568–572. [PubMed]
  • Upadhyay MP, Karmacharya PC, Koirala S, Tuladhar NR, Bryan LE, Smolin G, Whitcher JP. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991 Jan 15;111(1):92–99. [PubMed]
  • WARREN CM., Jr DANGERS OF STEROIDS IN OPHTHALMOLOGY WITH REPORT OF A CASE OF MYCOTIC PERFORATING CORNEAL ULCER. J Med Assoc State Ala. 1964 Feb;33:229–233. [PubMed]
  • GEORG LK. CURVULARIA GENICULATA, A CAUSE OF MYCOTIC KERATITIS. J Med Assoc State Ala. 1964 Feb;33:234–236. [PubMed]
  • Williams G, McClellan K, Billson F. Suppurative keratitis in rural Bangladesh: the value of gram stain in planning management. Int Ophthalmol. 1991 Mar;15(2):131–135. [PubMed]
  • Wilson LA, Ahearn DG. Association of fungi with extended-wear soft contact lenses. Am J Ophthalmol. 1986 Apr 15;101(4):434–436. [PubMed]
  • Wind CA, Polack FM. Keratomycosis due to Curvularia lunata. Arch Ophthalmol. 1970 Nov;84(5):694–696. [PubMed]
  • Polack FM, Kaufman HE, Newmark E. Keratomycosis. Medical and surgical treatment. Arch Ophthalmol. 1971 Apr;85(4):410–416. [PubMed]
  • Wong TY, Fong KS, Tan DT. Clinical and microbial spectrum of fungal keratitis in Singapore: a 5-year retrospective study. Int Ophthalmol. 1997;21(3):127–130. [PubMed]
  • Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J. 1997 Oct;23(4):275–281. [PubMed]
  • Wood TO, Tuberville AW, Monnett R. Keratomycosis and amphotericin B. Trans Am Ophthalmol Soc. 1985;83:397–409. [PMC free article] [PubMed]
  • McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol. 1983 Jan;8(1):1–16. [PubMed]
  • Fader RC, McGinnis MR. Infections caused by dematiaceous fungi: chromoblastomycosis and phaeohyphomycosis. Infect Dis Clin North Am. 1988 Dec;2(4):925–938. [PubMed]
  • Flournoy DJ, Mullins JB, McNeal RJ. Isolation of fungi from rose bush thorns. J Okla State Med Assoc. 2000 Jul;93(7):271–274. [PubMed]
  • Takatori M, Shida T, Akiyama K, Takatori K. [Airborne fungi during the last ten years in Sagamihara]. Arerugi. 1994 Jan;43(1):1–8. [PubMed]
  • Ogunlana EO. Fungal air spora at Ibadan, Nigeria. Appl Microbiol. 1975 Apr;29(4):458–463. [PMC free article] [PubMed]
  • Gaglani MJ, Friedman J, Hawkins EP, Campbell JR. Infections complicating lawn mower injuries in children. Pediatr Infect Dis J. 1996 May;15(5):452–455. [PubMed]
  • Simmons RB, Buffington JR, Ward M, Wilson LA, Ahearn DG. Morphology and ultrastructure of fungi in extended-wear soft contact lenses. J Clin Microbiol. 1986 Jul;24(1):21–25. [PMC free article] [PubMed]
  • Wilson LA, Kuehne JW, Hall SW, Ahearn DG. Microbial contamination in ocular cosmetics. Am J Ophthalmol. 1971 Jun;71(6):1298–1302. [PubMed]
  • Wilson LA, Ahearn DG, Jones DB, Sexton RR. Fungi from the normal outer eye. Am J Ophthalmol. 1969 Jan;67(1):52–56. [PubMed]
  • Ando N, Takatori K. Fungal flora of the conjunctival sac. Am J Ophthalmol. 1982 Jul;94(1):67–74. [PubMed]
  • Sehgal SC, Dhawan S, Chhiber S, Sharma M, Talwar P. Frequency and significance of fungal isolations from conjunctival sac and their role in ocular infections. Mycopathologia. 1981 Jan 30;73(1):17–19. [PubMed]
  • Qualls CW, Jr, Chandler FW, Kaplan W, Breitschwerdt EB, Cho DY. Mycotic keratitis in a dog: concurrent Aspergillus sp and Curvularia sp infections. J Am Vet Med Assoc. 1985 May 1;186(9):975–976. [PubMed]
  • Andrew SE, Brooks DE, Smith PJ, Gelatt KN, Chmielewski NT, Whittaker CJ. Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987-1996). Equine Vet J. 1998 Mar;30(2):109–116. [PubMed]
  • Kodikara DS, De Silva N, Makuloluwa CAB, De Silva N, Gunatilake M. Bacterial and fungal pathogens isolated from corneal ulcerations in domesticated elephants (Elephas maximus maximus) in Sri Lanka. Vet Ophthalmol. 1999;2(3):191–192. [PubMed]
  • Samuelson DA, Andresen TL, Gwin RM. Conjunctival fungal flora in horses, cattle, dogs, and cats. J Am Vet Med Assoc. 1984 May 15;184(10):1240–1242. [PubMed]
  • Gupta R, Singh BP, Sridhara S, Gaur SN, Chaudhary VK, Arora N. Allergens of Curvularia lunata during cultivation in different media. J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):857–862. [PubMed]
  • Robinson N, Gibson TM, Chicarelli-Robinson MI, Cameron L, Hylands PJ, Wilkinson D, Simpson TJ. Cochliobolic acid, a novel metabolite produced by Cochliobolus lunatus, inhibits binding of TGF-alpha to the EGF receptor in a SPA assay. J Nat Prod. 1997 Jan;60(1):6–8. [PubMed]
  • Rout N, Nanda BK, Gangopadhyaya S. Experimental pheohyphomycosis and mycotoxicosis by Curvularia lunata in albino rats. Indian J Pathol Microbiol. 1989 Jan;32(1):1–6. [PubMed]
  • Whitcomb MP, Jeffries CD, Weise RW. Curvularia lunata in experimental phaeohyphomycosis. Mycopathologia. 1981 Aug 7;75(2):81–88. [PubMed]
  • Jones DB, Sexton R, Rebell G. Mycotic keratitis in South Florida: a review of thirty-nine cases. Trans Ophthalmol Soc U K. 1970;89:781–797. [PubMed]
  • O'Day DM, Head WS, Robinson RD, Clanton JA. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res. 1986 Nov;5(11):877–882. [PubMed]
  • Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother. 1997 Apr;41(4):841–843. [PMC free article] [PubMed]
  • McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR, Jr, Rinaldi MG. In vitro activity of voriconazole against selected fungi. Med Mycol. 1998 Aug;36(4):239–242. [PubMed]
  • Jones BR. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am J Ophthalmol. 1975 May;79(5):719–751. [PubMed]
  • Garg P, Gopinathan U, Choudhary K, Rao GN. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology. 2000 Mar;107(3):574–580. [PubMed]
  • Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980 Jul;90(1):38–47. [PubMed]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society